230 related articles for article (PubMed ID: 32012923)
1. MicroRNAs and Neutrophil Activation Markers Predict Venous Thrombosis in Pancreatic Ductal Adenocarcinoma and Distal Extrahepatic Cholangiocarcinoma.
Oto J; Navarro S; Larsen AC; Solmoirago MJ; Plana E; Hervás D; Fernández-Pardo Á; España F; Kristensen SR; Thorlacius-Ussing O; Medina P
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32012923
[TBL] [Abstract][Full Text] [Related]
2. Increase of Neutrophil Activation Markers in Venous Thrombosis-Contribution of Circulating Activated Protein C.
Martos L; Oto J; Fernández-Pardo Á; Plana E; Solmoirago MJ; Cana F; Hervás D; Bonanad S; Ferrando F; España F; Navarro S; Medina P
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32781781
[TBL] [Abstract][Full Text] [Related]
3. microRNAs and Markers of Neutrophil Activation as Predictors of Early Incidental Post-Surgical Pulmonary Embolism in Patients with Intracranial Tumors.
Oto J; Plana E; Solmoirago MJ; Fernández-Pardo Á; Hervás D; Cana F; España F; Artoni A; Bucciarelli P; Carrabba G; Navarro S; Merati G; Medina P
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32545233
[TBL] [Abstract][Full Text] [Related]
4. Incidence of Venous Thromboembolism in Patients With Newly Diagnosed Pancreatic Cancer and Factors Associated With Outcomes.
Frere C; Bournet B; Gourgou S; Fraisse J; Canivet C; Connors JM; Buscail L; Farge D;
Gastroenterology; 2020 Apr; 158(5):1346-1358.e4. PubMed ID: 31843588
[TBL] [Abstract][Full Text] [Related]
5. Citrullinated histone H3, a biomarker of neutrophil extracellular trap formation, predicts the risk of venous thromboembolism in cancer patients.
Mauracher LM; Posch F; Martinod K; Grilz E; Däullary T; Hell L; Brostjan C; Zielinski C; Ay C; Wagner DD; Pabinger I; Thaler J
J Thromb Haemost; 2018 Mar; 16(3):508-518. PubMed ID: 29325226
[TBL] [Abstract][Full Text] [Related]
6. A pilot study to develop a diagnostic test for pancreatic ductal adenocarcinoma based on differential expression of select miRNA in plasma and bile.
Cote GA; Gore AJ; McElyea SD; Heathers LE; Xu H; Sherman S; Korc M
Am J Gastroenterol; 2014 Dec; 109(12):1942-52. PubMed ID: 25350767
[TBL] [Abstract][Full Text] [Related]
7. Venous thrombosis in pancreaticobiliary tract cancer: outcome and prognostic factors.
Larsen AC; Brøndum Frøkjaer J; Wishwanath Iyer V; Vincents Fisker R; Sall M; Yilmaz MK; Kuno Møller B; Kristensen SR; Thorlacius-Ussing O
J Thromb Haemost; 2015 Apr; 13(4):555-62. PubMed ID: 25594256
[TBL] [Abstract][Full Text] [Related]
8. Cell-free plasma microRNA in pancreatic ductal adenocarcinoma and disease controls.
Carlsen AL; Joergensen MT; Knudsen S; de Muckadell OB; Heegaard NH
Pancreas; 2013 Oct; 42(7):1107-13. PubMed ID: 24048453
[TBL] [Abstract][Full Text] [Related]
9. Venous thromboembolism in patients with cholangiocarcinoma: focus on risk factors and impact on survival.
Jeon HK; Kim DU; Baek DH; Ha DW; Lee BE; Ryu DY; Cheong JH; Kim GH; Song GA; Jang AL
Eur J Gastroenterol Hepatol; 2012 Apr; 24(4):444-9. PubMed ID: 22410715
[TBL] [Abstract][Full Text] [Related]
10. Symptomatic and incidental thromboembolism are both associated with mortality in pancreatic cancer.
Menapace LA; Peterson DR; Berry A; Sousou T; Khorana AA
Thromb Haemost; 2011 Aug; 106(2):371-8. PubMed ID: 21713322
[TBL] [Abstract][Full Text] [Related]
11. Infiltrating immune cells and gene mutations in pancreatic ductal adenocarcinoma.
Wang WQ; Liu L; Xu HX; Wu CT; Xiang JF; Xu J; Liu C; Long J; Ni QX; Yu XJ
Br J Surg; 2016 Aug; 103(9):1189-99. PubMed ID: 27256393
[TBL] [Abstract][Full Text] [Related]
12. Identification of candidate miRNA biomarkers for pancreatic ductal adenocarcinoma by weighted gene co-expression network analysis.
Giulietti M; Occhipinti G; Principato G; Piva F
Cell Oncol (Dordr); 2017 Apr; 40(2):181-192. PubMed ID: 28205147
[TBL] [Abstract][Full Text] [Related]
13. Markers of neutrophil activation and neutrophil extracellular traps in diagnosing patients with acute venous thromboembolism: A feasibility study based on two VTE cohorts.
Smith P; Rosell A; Farm M; Bruzelius M; Aguilera Gatica K; Mackman N; Odeberg J; Thålin C
PLoS One; 2022; 17(7):e0270865. PubMed ID: 35901107
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA modulated networks of adaptive and innate immune response in pancreatic ductal adenocarcinoma.
Felix TF; Lopez Lapa RM; de Carvalho M; Bertoni N; Tokar T; Oliveira RA; M Rodrigues MA; Hasimoto CN; Oliveira WK; Pelafsky L; Spadella CT; Llanos JC; F Silva G; Lam WL; Rogatto SR; Amorim LS; Drigo SA; Carvalho RF; Reis PP
PLoS One; 2019; 14(5):e0217421. PubMed ID: 31150430
[TBL] [Abstract][Full Text] [Related]
15. Analysis of Blood Plasma MicroRNAs to Enable Identification of Patients with Pancreatic Ductal Adenocarcinoma Who Will Benefit from Surgical Resection.
Gablo N. A; Procházka V; Hlavsa J; Kiss I; Srovnal J; Kala Z; Slabý O
Klin Onkol; 2019; 32(Suppl 1):174-176. PubMed ID: 31064193
[TBL] [Abstract][Full Text] [Related]
16. Circulating nucleosomes and neutrophil activation as risk factors for deep vein thrombosis.
van Montfoort ML; Stephan F; Lauw MN; Hutten BA; Van Mierlo GJ; Solati S; Middeldorp S; Meijers JC; Zeerleder S
Arterioscler Thromb Vasc Biol; 2013 Jan; 33(1):147-51. PubMed ID: 23104849
[TBL] [Abstract][Full Text] [Related]
17. A genome-wide investigation of microRNA expression identifies biologically-meaningful microRNAs that distinguish between high-risk and low-risk intraductal papillary mucinous neoplasms of the pancreas.
Permuth-Wey J; Chen YA; Fisher K; McCarthy S; Qu X; Lloyd MC; Kasprzak A; Fournier M; Williams VL; Ghia KM; Yoder SJ; Hall L; Georgeades C; Olaoye F; Husain K; Springett GM; Chen DT; Yeatman T; Centeno BA; Klapman J; Coppola D; Malafa M
PLoS One; 2015; 10(1):e0116869. PubMed ID: 25607660
[TBL] [Abstract][Full Text] [Related]
18. miR-186 and 326 predict the prognosis of pancreatic ductal adenocarcinoma and affect the proliferation and migration of cancer cells.
Zhang ZL; Bai ZH; Wang XB; Bai L; Miao F; Pei HH
PLoS One; 2015; 10(3):e0118814. PubMed ID: 25742499
[TBL] [Abstract][Full Text] [Related]
19. Global microRNA expression profiling of microdissected tissues identifies miR-135b as a novel biomarker for pancreatic ductal adenocarcinoma.
Munding JB; Adai AT; Maghnouj A; Urbanik A; Zöllner H; Liffers ST; Chromik AM; Uhl W; Szafranska-Schwarzbach AE; Tannapfel A; Hahn SA
Int J Cancer; 2012 Jul; 131(2):E86-95. PubMed ID: 21953293
[TBL] [Abstract][Full Text] [Related]
20. Cellular Components Contributing to the Development of Venous Thrombosis in Patients with Pancreatic Cancer.
Willems RAL; Biesmans C; Campello E; Simioni P; de Laat B; de Vos-Geelen J; Roest M; Ten Cate H
Semin Thromb Hemost; 2024 Apr; 50(3):429-442. PubMed ID: 38049115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
